Karen Bayliss

Karen Bayliss is currently the Head of Sales at Myogenes, specializing in pharmacogenomic testing for individualized treatment. Karen also serves as the Head of Sales at Psychiatric Genetic Testing, where Karen introduced the first pharmacogenetic test for patients with treatment resistant schizophrenia. With previous experience as a Key Account Manager at Recordati, Sunovion Pharmaceuticals, and Lundbeck, Karen has a strong background in launching and commercializing various pharmaceutical products in the UK market.